Lymphotactin gene-modified bone marrow dendritic cells act as more potent adjuvants for peptide delivery to induce specific antitumor immunity
about
Overexpression of CCL-21/secondary lymphoid tissue chemokine in human dendritic cells augments chemotactic activities for lymphocytes and antigen presenting cellsExpression of the T-cell chemoattractant chemokine lymphotactin in Crohn's diseaseIdentification of a novel conserved HLA-A*0201-restricted epitope from the spike protein of SARS-CoV.Efficient induction of a Her2-specific anti-tumor response by dendritic cells pulsed with a Hsp70L1-Her2(341-456) fusion protein.A parenteral DNA vaccine protects against pneumonic plagueLymphotactin enhances the in-vitro immune efficacy of dendritoma formed by dendritic cells and mouse hepatocellular carcinoma cellsMacrophage inflammatory protein 3alpha transgene attracts dendritic cells to established murine tumors and suppresses tumor growth.Comparative analysis of genetically modified dendritic cells and tumor cells as therapeutic cancer vaccines.Trial watch: Dendritic cell-based interventions for cancer therapyTREM-2 serves as a negative immune regulator through Syk pathway in an IL-10 dependent manner in lung cancer.CpG-ODN-stimulated dendritic cells act as a potent adjuvant for E7 protein delivery to induce antigen-specific antitumour immunity in a HPV 16 E7-associated animal tumour model.
P2860
Q24793668-D2B5876C-10B0-4A9D-AEE9-632BCC2165A9Q28363385-FC68FADD-87CF-4414-9867-09AD1331BAB8Q30951751-99EAB633-00C2-4AA6-BE60-FD18FE3C3F3DQ33577507-8E0AB62E-A340-402F-8F04-B7372DC9CE1FQ33816162-B7CC1A6B-0B28-40BA-B1CA-32D46C0786EEQ34423195-853E17BC-389D-425F-9B84-C10C22CA43C5Q35159565-D5A3D793-5E38-4F5E-A13E-730618FC6973Q36368444-FEC7DA36-6FD9-49E1-AE1C-5C3351927607Q36388529-6DA9986D-CBCD-4675-89DD-513181CFEB4EQ37301896-E03CB1AC-0300-41C7-B7DD-F38DAE54EB28Q47736286-45185B34-2361-44C4-8307-C33AF54009B0
P2860
Lymphotactin gene-modified bone marrow dendritic cells act as more potent adjuvants for peptide delivery to induce specific antitumor immunity
description
1998 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 1998
@ast
im Dezember 1998 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1998/12/01)
@sk
vědecký článek publikovaný v roce 1998
@cs
wetenschappelijk artikel (gepubliceerd op 1998/12/01)
@nl
наукова стаття, опублікована в грудні 1998
@uk
مقالة علمية (نشرت في ديسمبر 1998)
@ar
name
Lymphotactin gene-modified bon ...... ce specific antitumor immunity
@ast
Lymphotactin gene-modified bon ...... ce specific antitumor immunity
@en
Lymphotactin gene-modified bon ...... ce specific antitumor immunity
@nl
type
label
Lymphotactin gene-modified bon ...... ce specific antitumor immunity
@ast
Lymphotactin gene-modified bon ...... ce specific antitumor immunity
@en
Lymphotactin gene-modified bon ...... ce specific antitumor immunity
@nl
prefLabel
Lymphotactin gene-modified bon ...... ce specific antitumor immunity
@ast
Lymphotactin gene-modified bon ...... ce specific antitumor immunity
@en
Lymphotactin gene-modified bon ...... ce specific antitumor immunity
@nl
P2093
P3181
P1476
Lymphotactin gene-modified bon ...... ce specific antitumor immunity
@en
P2093
P304
P3181
P407
P577
1998-12-01T00:00:00Z